Agaricus Blazei
Supplement
Agaricus Blazei is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.
Pharmacokinetic model
A route-level PK model for agaricus blazei is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Supplement
- Suggested cadence
- once daily
Research behind this entry
-
The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.
This citation reports a human clinical study involving Agaricus Blazei. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.
1 published study referenced in the app, each with a plain-language summary.